Epitope-based ligation of ICAM-1: Therapeutic target for protection against the development of rheumatoid arthritis

Jae Il Lee, Hi Jung Park, Hye Jin Park, Yun Jung Choi, Jiyeon Kim, Jin Kyun Park, Kyeong Cheon Jung, Eung Soo Hwang, Eun Bong Lee, Seong Hoe Park

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Identification of a particular epitope on the domain 2 of human ICAM-1 led us to focus on its role in the treatment of rheumatoid arthritis (RA). Key observations from our previous xenotransplantation research included the generation of tolerogenic DCs, antigen-specific T-cell tolerance, and reduced production of inflammatory cytokines. The critically important point is the fact that it works initially on DC maturation. Ligation of this epitope with a recognizing antibody, MD-3, was also able to create a tolerogenic environment in RA in a manner sililar to that created by xenotransplantation. In this study, we noted that the disease progression, in terms of arthritis score and histopathology of joints, was significantly less severe in the MD-3-treated group than in the vehicle-treated group. Defective production of IL-6 and reduced proliferation of collagen-specific T cells were most remarkable laboratory findings. This type of ligation has a greater advantage over other types of therapeutics, in a sense that simple injection of this antibody inhibits antigen-specific T cell response. Due to the possibility of viral infection in this process, we regularly monitored cytomegalovirus reactivation status without detection of any viral gene replication. We are hoping that remarkable specializations that this interaction has, would be a promising target for therapeutic antibody in RA.

Original languageEnglish
Pages (from-to)450-455
Number of pages6
JournalBiochemical and Biophysical Research Communications
Issue number2
StatePublished - Jun 2 2018


  • Anti-ICAM-1antibody
  • Antigen-specific
  • Collagen-induced arthritis
  • In situ induction
  • MD-3


Dive into the research topics of 'Epitope-based ligation of ICAM-1: Therapeutic target for protection against the development of rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this